Synovial sarcoma of the vulva: A case report and literature review with discussion on fertility sparing approaches.

Gabriella Schoettle, Stephanie Gulstene, Jason Vickress, Akira Sugimoto, David D'Souza

Open access · goldAbstract readCase Reports

In one paragraph

Article in Gynecologic oncology reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

0.8field-weighted citation impact, top 27% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Gabriella SchoettleSchulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.

Stephanie GulsteneSchulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.

Jason VickressDivision of Radiation Oncology, Department of Oncology, London Health Sciences Centre, London, Ontario, Canada.

Akira SugimotoSchulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.

David D'SouzaSchulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.

London Health Sciences Centre · CAWestern University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

•Vulvar synovial sarcoma is a rare malignancy with unclear treatment guidelines but usually includes surgical resection.•Our literature review demonstrates additional survival benefit from addition of radiotherapy to surgical resection.•There is no specific guidance in the literature for the addition of systemic agents to treat vulvovaginal disease.•Our patient received wide surgical excision and IMRT radiotherapy with no signs of recurrence 2 years from treatment.•She conceived after treatment. This has only been documented once before with different, less accessible treatments.

Indexed as

External beam radiotherapyGynecologic oncologyRadiation oncologySynovial sarcomaVulvar malignancy

Identifiers

PMID36659908

DOI10.1016/j.gore.2023.101132

PMCPMC9842853

OpenAlexW4313731135

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.